ReviewCurrent microbiology2026
Hantaviruses as Emerging Zoonotic Pathogens: Molecular Biology, Epidemiology, Therapeutics, vaccine, and Pathogenesis.
Review in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hantaviruses are globally distributed zoonotic pathogens belonging to the family Hantaviridae and are responsible for two major human diseases, hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). Despite substantial progress in hantavirus research, important challenges remain in understanding the interactions among viral evolution, reservoir ecology, environmental change, transmission dynamics, and host immunopathology. This review provides an integrated One Health perspective that connects molecular virology and host-virus interactions with transmission ecology, global epidemiology, and the mechanisms underlying vascular leakage and severe disease. In addition to summarizing established knowledge, we highlight recent advances in hantavirus taxonomy, genomic and molecular surveillance, ecological and transmission modeling, and the identification of hantavirus circulation in previously underrecognized regions. Particular emphasis is placed on the role of reservoir host dynamics, climate and environmental change, habitat disturbance, and human-wildlife interactions in shaping spillover risk, as well as on endothelial dysfunction, immune dysregulation, and coagulation abnormalities as interconnected mechanisms of disease severity. We also identify persistent knowledge gaps concerning host susceptibility, viral persistence, determinants of differential virulence and tissue tropism, interspecies transmission, and the development of effective antiviral therapies and vaccines. By integrating these complementary perspectives, this review provides a framework for understanding hantavirus emergence and pathogenesis while identifying priorities for future surveillance, prevention, and therapeutic research.
Indexed as
Identifiers
42902055What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.